ClinConnect ClinConnect Logo
Search / Trial NCT06631794

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

Launched by HOPITAL FOCH · Oct 7, 2024

Trial Information

Current as of July 04, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a talk about the HPV vaccine affects whether teenagers decide to get vaccinated. The study will take place in two towns where some third-grade students will receive information about the importance of the HPV vaccine, while students in two other towns will not have this talk. By comparing these groups, researchers hope to see if the talk encourages more students to get vaccinated.

To participate in this trial, students need to be in the third grade at public secondary schools in Suresnes or Rueil-Malmaison. Students who are absent on the day of the talk or who do not want to fill out a questionnaire will not be included. If your child is eligible, they can expect to learn about the vaccine and share their thoughts through a simple questionnaire afterward. It’s an opportunity to help understand how education about vaccines can influence health choices among young people.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.
  • Exclusion Criteria:
  • Students absent on the day of the talk.
  • Students unwilling/unable to complete questionnaire.

About Hopital Foch

Hospital Foch is a leading healthcare institution located in Suresnes, France, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, Hospital Foch actively engages in the development of new therapeutic approaches across various medical disciplines, facilitating cutting-edge studies that aim to enhance treatment outcomes and improve patient quality of life. With a multidisciplinary team of experienced researchers and healthcare professionals, the hospital fosters a collaborative environment that prioritizes ethical standards and scientific rigor, ensuring the highest quality in clinical trial execution and patient safety.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported